{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:19:04Z","timestamp":1788308344082,"version":"build-2803163510"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02232-1","type":"journal-article","created":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T03:44:15Z","timestamp":1782013455000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The oncogenic role, regulatory mechanism, and clinical significance of lncRNA HIF1A-AS2 in multiple human cancers"],"prefix":"10.1007","volume":"26","author":[{"given":"Lei","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,21]]},"reference":[{"issue":"3","key":"2232_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"2232_CR2","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","volume":"135","author":"C Xia","year":"2022","unstructured":"Xia C, Dong X, Li H, Cao M, Sun D, He S, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl). 2022;135(5):584\u201390.","journal-title":"Chin Med J (Engl)"},{"issue":"4","key":"2232_CR3","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.ccell.2023.03.012","volume":"41","author":"ES Hwang","year":"2023","unstructured":"Hwang ES, Reading J, Yu J, Dotto GP, Grady WM, Czerniak B, et al. Pre-cancer: From diagnosis to intervention opportunities. Cancer Cell. 2023;41(4):637\u201340.","journal-title":"Cancer Cell"},{"issue":"15","key":"2232_CR4","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.3390\/molecules29153461","volume":"29","author":"F Ma","year":"2024","unstructured":"Ma F, Zhang B, Wang Y, Lou C, Long Non-Coding. RNA AGAP2-AS1: A Comprehensive Overview on Its Biological Functions and Clinical Significances in Human Cancers. Molecules. 2024;29(15):3461.","journal-title":"Molecules"},{"issue":"1","key":"2232_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s13148-025-02015-7","volume":"17","author":"G Tian","year":"2025","unstructured":"Tian G, Zheng D, Zhang N, Deng W, Xu J, Huang C, et al. Association of blood-based DNA methylation of lncRNAs with Alzheimer\u2019s disease diagnosis. Clin Epigenetics. 2025;17(1):200.","journal-title":"Clin Epigenetics"},{"issue":"12","key":"2232_CR6","doi-asserted-by":"publisher","first-page":"16641","DOI":"10.1007\/s00210-025-04402-6","volume":"398","author":"SA Jasim","year":"2025","unstructured":"Jasim SA, Pallathadka H, Hjazi A, Sanghvi G, M M R, Agarwal M, et al. LncRNA-Histone Modification Crosstalk: Orchestrating Cancer Pathobiology. Naunyn Schmiedebergs Arch Pharmacol. 2025;398(12):16641\u201360.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"6","key":"2232_CR7","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41417-024-00734-2","volume":"31","author":"L Yang","year":"2024","unstructured":"Yang L, Tang L, Min Q, Tian H, Li L, Zhao Y, et al. Emerging role of RNA modification and long noncoding RNA interaction in cancer. Cancer Gene Ther. 2024;31(6):816\u201330.","journal-title":"Cancer Gene Ther"},{"key":"2232_CR8","doi-asserted-by":"publisher","first-page":"155333","DOI":"10.1016\/j.prp.2024.155333","volume":"258","author":"R Siddique","year":"2024","unstructured":"Siddique R, Thangavelu L, Almalki SR, Kazmi WH, Kumar I, Mahajan A. lncRNAs and cyclin-dependent kinases: Unveiling their critical roles in cancer progression. Pathol Res Pract. 2024;258:155333.","journal-title":"Pathol Res Pract"},{"issue":"3","key":"2232_CR9","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1007\/s12013-024-01411-9","volume":"82","author":"W Wu","year":"2024","unstructured":"Wu W, Li X, Li X, Zhao J, Gui Y, Luo Y, et al. The Role of Long Non-Coding RNF144A-AS1 in Cancer Progression. Cell Biochem Biophys. 2024;82(3):2007\u201317.","journal-title":"Cell Biochem Biophys"},{"issue":"4","key":"2232_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3892\/br.2021.1461","volume":"15","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhang Y, Chen C, Li Y, lncRNA. HIF1A-AS2: A potential oncogene in human cancers (Review). Biomed Rep. 2021;15(4):85.","journal-title":"Biomed Rep"},{"issue":"2","key":"2232_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/jnci\/91.2.143","volume":"91","author":"CA Thrash-Bingham","year":"1999","unstructured":"Thrash-Bingham CA, Tartof KD. aHIF: a natural antisense transcript overexpressed in human renal cancer and during hypoxia. J Natl Cancer Inst. 1999;91(2):143\u201351.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"2232_CR12","doi-asserted-by":"publisher","first-page":"102249","DOI":"10.3748\/wjg.v31.i5.102249","volume":"31","author":"ZY Yao","year":"2025","unstructured":"Yao ZY, Ma X, Cui YZ, Liu J, Han ZX, Song J. Impact of triglyceride-glucose index on the long-term prognosis of advanced gastric cancer patients receiving immunotherapy combined with chemotherapy. World J Gastroenterol. 2025;31(5):102249.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"2232_CR13","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1093\/jjco\/hyaf055","volume":"55","author":"Y Yanagimoto","year":"2025","unstructured":"Yanagimoto Y, Yamamoto K, Hara K, Masuike Y, Ushimaru Y, Kitamura M, et al. Two cases of protein-losing enteropathy induced by zolbetuximab in patients with unresectable advanced gastric cancer. Jpn J Clin Oncol. 2025;55(7):825\u201331.","journal-title":"Jpn J Clin Oncol"},{"issue":"6","key":"2232_CR14","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1007\/s10620-015-3524-0","volume":"60","author":"WM Chen","year":"2015","unstructured":"Chen WM, Huang MD, Kong R, Xu TP, Zhang EB, Xia R, et al. Antisense Long Noncoding RNA HIF1A-AS2 Is Upregulated in Gastric Cancer and Associated with Poor Prognosis. Dig Dis Sci. 2015;60(6):1655\u201362.","journal-title":"Dig Dis Sci"},{"key":"2232_CR15","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.2147\/CMAR.S543448","volume":"17","author":"L Niu","year":"2025","unstructured":"Niu L, Nie Y, Liu Q. Diagnostic and Prognostic Values of HIF1A-AS2 and LINC00511 in Gastric Cancer with Helicobacter pylori Infection. Cancer Manag Res. 2025;17:2773\u201383.","journal-title":"Cancer Manag Res"},{"issue":"12","key":"2232_CR16","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1007\/s10620-020-06819-w","volume":"66","author":"L Mu","year":"2021","unstructured":"Mu L, Wang Y, Su H, Lin Y, Sui W, Yu X, et al. HIF1A-AS2 Promotes the Proliferation and Metastasis of Gastric Cancer Cells Through miR-429\/PD-L1 Axis. Dig Dis Sci. 2021;66(12):4314\u201325.","journal-title":"Dig Dis Sci"},{"issue":"5","key":"2232_CR17","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1158\/0008-5472.CAN-23-2625","volume":"84","author":"X Wu","year":"2024","unstructured":"Wu X, Li X, Wang L, Bi X, Zhong W, Yue J, et al. Lysine Deacetylation Is a Key Function of the Lysyl Oxidase Family of Proteins in Cancer. Cancer Res. 2024;84(5):652\u20138.","journal-title":"Cancer Res"},{"key":"2232_CR18","doi-asserted-by":"publisher","first-page":"760470","DOI":"10.3389\/fcell.2021.760470","volume":"9","author":"A Nai","year":"2022","unstructured":"Nai A, Zeng H, Wu Q, He Z, Zeng S, Bashir S, et al. lncRNA\/miR-29c-Mediated High Expression of LOX Can Influence the Immune Status and Chemosensitivity and Can Forecast the Poor Prognosis of Gastric Cancer. Front Cell Dev Biol. 2022;9:760470.","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"2232_CR19","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S2468-1253(21)00426-X","volume":"7","author":"SG Patel","year":"2022","unstructured":"Patel SG, Karlitz JJ, Yen T, Lieu CH, Boland CR. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. Lancet Gastroenterol Hepatol. 2022;7(3):262\u201374.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"2232_CR20","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1111\/cbdd.14036","volume":"101","author":"MO Olatubosun","year":"2023","unstructured":"Olatubosun MO, Abubakar MB, Batiha GE, Malami I, Ibrahim KG, Abubakar B, et al. LncRNA SNHG15: A potential therapeutic target in the treatment of colorectal cancer. Chem Biol Drug Des. 2023;101(5):1138\u201350.","journal-title":"Chem Biol Drug Des"},{"issue":"12","key":"2232_CR21","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.2174\/0115665240339328241217184041","volume":"25","author":"O Anbiyaee","year":"2025","unstructured":"Anbiyaee O, Ghaedrahmati F, Azizidoost S, Radmehr S, Farzaneh M, Salehi AM. LncRNA-DANCR: A Key Player in Colorectal Cancer Development and Progression. Curr Mol Med. 2025;25(12):1441\u20139.","journal-title":"Curr Mol Med"},{"key":"2232_CR22","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.biopha.2017.12.058","volume":"98","author":"J Lin","year":"2018","unstructured":"Lin J, Shi Z, Yu Z, He Z. LncRNA HIF1A-AS2 positively affects the progression and EMT formation of colorectal cancer through regulating miR-129-5p and DNMT3A. Biomed Pharmacother. 2018;98:433\u20139.","journal-title":"Biomed Pharmacother"},{"key":"2232_CR23","doi-asserted-by":"publisher","first-page":"148079","DOI":"10.1016\/j.gene.2023.148079","volume":"897","author":"Y Yang","year":"2024","unstructured":"Yang Y, Li W, Yang H, Zhang Y, Zhang S, Xu F, et al. Research progress on the regulatory mechanisms of FOXC1 expression in cancers and its role in drug resistance. Gene. 2024;897:148079.","journal-title":"Gene"},{"issue":"9","key":"2232_CR24","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41419-024-06958-2","volume":"15","author":"X Zhong","year":"2024","unstructured":"Zhong X, Wang Y, He X, He X, Hu Z, Huang H, et al. HIF1A-AS2 promotes the metabolic reprogramming and progression of colorectal cancer via miR-141-3p\/FOXC1 axis. Cell Death Dis. 2024;15(9):645.","journal-title":"Cell Death Dis"},{"issue":"3","key":"2232_CR25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2174\/1566524023666230816163031","volume":"25","author":"M Sheykhhasan","year":"2025","unstructured":"Sheykhhasan M, Dermani F, Gheibi N, Datta I, Sadeghi H, Khoei SG. The Emerging Role of LncRNA AWPPH in Multiple Cancers: A Review Study. Curr Mol Med. 2025;25(3):237\u201368.","journal-title":"Curr Mol Med"},{"issue":"10","key":"2232_CR26","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1158\/2326-6066.CIR-23-0622","volume":"12","author":"TT Liao","year":"2024","unstructured":"Liao TT, Chen YH, Li ZY, Hsiao AC, Huang YL, Hao RX, et al. Hypoxia-Induced Long Noncoding RNA HIF1A-AS2 Regulates Stability of MHC Class I Protein in Head and Neck Cancer. Cancer Immunol Res. 2024;12(10):1468\u201384.","journal-title":"Cancer Immunol Res"},{"key":"2232_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.semcancer.2023.09.002","volume":"96","author":"GL Semenza","year":"2023","unstructured":"Semenza GL. Targeting intratumoral hypoxia to enhance anti-tumor immunity. Semin Cancer Biol. 2023;96:5\u201310.","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"2232_CR28","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3390\/cells12060873","volume":"12","author":"HH Huang","year":"2023","unstructured":"Huang HH, You GR, Tang SJ, Chang JT, Cheng AJ. Molecular Signature of Long Non-Coding RNA Associated with Areca Nut-Induced Head and Neck Cancer. Cells. 2023;12(6):873.","journal-title":"Cells"},{"key":"2232_CR29","doi-asserted-by":"publisher","first-page":"217676","DOI":"10.1016\/j.canlet.2025.217676","volume":"620","author":"ZD Shi","year":"2025","unstructured":"Shi ZD, Liu Y, Tao ZQ, Chao L, Zhang ZG, Sun F, et al. Apigenin inhibits recurrent bladder cancer progression by targeting VEGF-\u03b2. Cancer Lett. 2025;620:217676.","journal-title":"Cancer Lett"},{"issue":"1","key":"2232_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.canlet.2016.03.037","volume":"376","author":"M Chen","year":"2016","unstructured":"Chen M, Zhuang C, Liu Y, Li J, Dai F, Xia M, et al. Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer. Cancer Lett. 2016;376(1):155\u201364.","journal-title":"Cancer Lett"},{"issue":"1","key":"2232_CR31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/jcb.27327","volume":"120","author":"X Chen","year":"2019","unstructured":"Chen X, Liu M, Meng F, Sun B, Jin X, Jia C. The long noncoding RNA HIF1A-AS2 facilitates cisplatin resistance in bladder cancer. J Cell Biochem. 2019;120(1):243\u201352.","journal-title":"J Cell Biochem"},{"issue":"1","key":"2232_CR32","doi-asserted-by":"publisher","first-page":"24621","DOI":"10.1038\/s41598-024-75544-5","volume":"14","author":"C Yang","year":"2024","unstructured":"Yang C, Tan Z, Wang Y, Bi R, Shi T, Yang J, et al. SwinUNeCCt: bidirectional hash-based agent transformer for cervical cancer MRI image multi-task learning. Sci Rep. 2024;14(1):24621.","journal-title":"Sci Rep"},{"issue":"11","key":"2232_CR33","first-page":"1615","volume":"40","author":"R Deng","year":"2020","unstructured":"Deng R, Zhang F, Lei F, Liu W, Liu S, Wang W. Silencing long non-coding RNA HIF1A-AS2 inhibits proliferation, invasion and migration of cervical cancer cells in vitro. Nan Fang Yi Ke Da Xue Xue Bao. 2020;40(11):1615\u201321.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"2232_CR34","doi-asserted-by":"publisher","first-page":"110390","DOI":"10.1016\/j.cellsig.2022.110390","volume":"97","author":"HM Guan","year":"2022","unstructured":"Guan HM, Li WQ, Liu J, Zhou JY. LncRNA HIF1A-AS2 modulated by HPV16 E6 regulates apoptosis of cervical cancer cells via P53\/caspase9\/caspase3 axis. Cell Signal. 2022;97:110390.","journal-title":"Cell Signal"},{"key":"2232_CR35","doi-asserted-by":"publisher","first-page":"103108","DOI":"10.1016\/j.redox.2024.103108","volume":"71","author":"Q Meng","year":"2024","unstructured":"Meng Q, Zhang Y, Sun H, Yang X, Hao S, Liu B, et al. Human papillomavirus-16 E6 activates the pentose phosphate pathway to promote cervical cancer cell proliferation by inhibiting G6PD lactylation. Redox Biol. 2024;71:103108.","journal-title":"Redox Biol"},{"key":"2232_CR36","doi-asserted-by":"publisher","first-page":"1530677","DOI":"10.3389\/fonc.2025.1530677","volume":"15","author":"Y Liu","year":"2025","unstructured":"Liu Y, Zhang Y, Chen C, Roy B, Li Q, Zhang W, et al. lncRNA HIF1A-AS2 acts as an oncogene to regulate malignant phenotypes in cervical cancer. Front Oncol. 2025;15:1530677.","journal-title":"Front Oncol"},{"key":"2232_CR37","doi-asserted-by":"publisher","first-page":"1660236","DOI":"10.3389\/fonc.2025.1660236","volume":"15","author":"L Song","year":"2025","unstructured":"Song L, Zhou JG, Ma H. The potential role of PIWI-interacting RNAs in non-small cell lung cancer. Front Oncol. 2025;15:1660236.","journal-title":"Front Oncol"},{"issue":"1","key":"2232_CR38","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s13046-025-03519-z","volume":"44","author":"H Wang","year":"2025","unstructured":"Wang H, Niu X, Jin Z, Zhang S, Fan R, Xiao H, et al. Immunotherapy resistance in non-small cell lung cancer: from mechanisms to therapeutic opportunities. J Exp Clin Cancer Res. 2025;44(1):250.","journal-title":"J Exp Clin Cancer Res"},{"key":"2232_CR39","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.omto.2023.02.007","volume":"28","author":"GR Hwang","year":"2023","unstructured":"Hwang GR, Yuen JG, Fesler A, Farley H, Haley JD, Ju J. Development of a 5-FU modified miR-129 mimic as a therapeutic for non-small cell lung cancer. Mol Ther Oncolytics. 2023;28:277\u201392.","journal-title":"Mol Ther Oncolytics"},{"key":"2232_CR40","doi-asserted-by":"publisher","first-page":"8715","DOI":"10.2147\/OTT.S262293","volume":"13","author":"W Zhang","year":"2020","unstructured":"Zhang W, Liu K, Pei Y, Tan J, Ma J, Zhao J. Long Noncoding RNA HIF1A-AS2 Promotes Non-Small Cell Lung Cancer Progression by the miR-153-5p\/S100A14 Axis. Onco Targets Ther. 2020;13:8715\u201322.","journal-title":"Onco Targets Ther"},{"issue":"6","key":"2232_CR41","doi-asserted-by":"publisher","first-page":"oyaf153","DOI":"10.1093\/oncolo\/oyaf153","volume":"30","author":"A Frisch","year":"2025","unstructured":"Frisch A, Martin E, Kim SY, Riess JW, Sen T, Karim N. KRAS mutated NSCLC: past, present, and future directions in a rapidly evolving landscape. Oncologist. 2025;30(6):oyaf153.","journal-title":"Oncologist"},{"issue":"6","key":"2232_CR42","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/s41418-023-01160-x","volume":"30","author":"K Yang","year":"2023","unstructured":"Yang K, Zhang W, Zhong L, Xiao Y, Sahoo S, Fassan M, et al. Long non-coding RNA HIF1A-As2 and MYC form a double-positive feedback loop to promote cell proliferation and metastasis in KRAS-driven non-small cell lung cancer. Cell Death Differ. 2023;30(6):1533\u201349.","journal-title":"Cell Death Differ"},{"key":"2232_CR43","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.omtn.2021.09.003","volume":"26","author":"J Si","year":"2021","unstructured":"Si J, Ma Y, Lv C, Hong Y, Tan H, Yang Y. HIF1A-AS2 induces osimertinib resistance in lung adenocarcinoma patients by regulating the miR-146b-5p\/IL-6\/STAT3 axis. Mol Ther Nucleic Acids. 2021;26:613\u201324.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"9","key":"2232_CR44","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12032-021-01562-2","volume":"38","author":"E G\u00fc\u00e7l\u00fc","year":"2021","unstructured":"G\u00fc\u00e7l\u00fc E, Ero\u011flu G\u00fcne\u015f C, Kurar E, Vural H. Knockdown of lncRNA HIF1A-AS2 increases drug sensitivity of SCLC cells in association with autophagy. Med Oncol. 2021;38(9):113.","journal-title":"Med Oncol"},{"issue":"1","key":"2232_CR45","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1186\/s12967-025-06793-9","volume":"23","author":"Y Yang","year":"2025","unstructured":"Yang Y, Fan R, Zhang B, Liu K. COL6A2 in clear cell renal cell carcinoma: a multifaceted driver of tumor progression, immune evasion, and drug sensitivity. J Transl Med. 2025;23(1):875.","journal-title":"J Transl Med"},{"key":"2232_CR46","doi-asserted-by":"publisher","first-page":"9807","DOI":"10.2147\/OTT.S260191","volume":"13","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, Yang Z, Chen H, Pan Y, Gong L, Chen F, et al. lncRNAHIF1A-AS2 Promotes Renal Carcinoma Cell Proliferation and Migration via miR-130a-5p\/ERBB2 Pathway. Onco Targets Ther. 2020;13:9807\u201320.","journal-title":"Onco Targets Ther"},{"issue":"2","key":"2232_CR47","doi-asserted-by":"publisher","first-page":"587","DOI":"10.20892\/j.issn.2095-3941.2020.0209","volume":"18","author":"M Chen","year":"2021","unstructured":"Chen M, Wei X, Shi X, Lu L, Zhang G, Huang Y, et al. LncRNA HIF1A-AS2 accelerates malignant phenotypes of renal carcinoma by modulating miR-30a-5p\/SOX4 axis as a ceRNA. Cancer Biol Med. 2021;18(2):587\u2013603.","journal-title":"Cancer Biol Med"},{"key":"2232_CR48","doi-asserted-by":"publisher","first-page":"115706","DOI":"10.1016\/j.bcp.2023.115706","volume":"215","author":"DJ Elson","year":"2023","unstructured":"Elson DJ, Nguyen BD, Korjeff NA, Wilferd SF, Puig-Sanvicens V, Sang Jang H, et al. Suppression of Ah Receptor (AhR) increases the aggressiveness of TNBC cells and 11-Cl-BBQ-activated AhR inhibits their growth. Biochem Pharmacol. 2023;215:115706.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"2232_CR49","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s12935-025-03832-9","volume":"25","author":"R Guo","year":"2025","unstructured":"Guo R, Wang X, Yang Y, Zou J, Li M, Li Z, et al. Prognostic value of a lncRNA signature in early-stage invasive breast cancer patients. Cancer Cell Int. 2025;25(1):233.","journal-title":"Cancer Cell Int"},{"issue":"9","key":"2232_CR50","doi-asserted-by":"publisher","first-page":"e6222","DOI":"10.1097\/MD.0000000000006222","volume":"96","author":"M Liu","year":"2017","unstructured":"Liu M, Xing LQ, Liu YJ. A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancers. Med (Baltim). 2017;96(9):e6222.","journal-title":"Med (Baltim)"},{"issue":"6","key":"2232_CR51","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1002\/jcb.28337","volume":"120","author":"Y Wang","year":"2019","unstructured":"Wang Y, Zhang G, Han J. HIF1A-AS2 predicts poor prognosis and regulates cell migration and invasion in triple-negative breast cancer. J Cell Biochem. 2019;120(6):10513\u20138.","journal-title":"J Cell Biochem"},{"issue":"37","key":"2232_CR52","doi-asserted-by":"publisher","first-page":"e21861","DOI":"10.1097\/MD.0000000000021861","volume":"99","author":"S Zhang","year":"2020","unstructured":"Zhang S, Ma F, Xie X, Shen Y. Prognostic value of long non-coding RNAs in triple negative breast cancer: A PRISMA-compliant meta-analysis. Med (Baltim). 2020;99(37):e21861.","journal-title":"Med (Baltim)"},{"issue":"24","key":"2232_CR53","doi-asserted-by":"publisher","first-page":"15864","DOI":"10.1021\/acsnano.4c02947","volume":"18","author":"X Qian","year":"2024","unstructured":"Qian X, Yang H, Ye Z, Gao B, Qian Z, Ding Y, et al. Celecoxib Augments Paclitaxel-Induced Immunogenic Cell Death in Triple-Negative Breast Cancer. ACS Nano. 2024;18(24):15864\u201377.","journal-title":"ACS Nano"},{"issue":"8","key":"2232_CR54","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1158\/0008-5472.CAN-15-3284","volume":"76","author":"YZ Jiang","year":"2016","unstructured":"Jiang YZ, Liu YR, Xu XE, Jin X, Hu X, Yu KD, et al. Transcriptome Analysis of Triple-Negative Breast Cancer Reveals an Integrated mRNA-lncRNA Signature with Predictive and Prognostic Value. Cancer Res. 2016;76(8):2105\u201314.","journal-title":"Cancer Res"},{"issue":"17","key":"2232_CR55","doi-asserted-by":"publisher","first-page":"e36469","DOI":"10.1016\/j.heliyon.2024.e36469","volume":"10","author":"L Min","year":"2024","unstructured":"Min L, Chen L, Huang D, Zhang Y, You A, Yan X, et al. LncRNA HIF1A-AS2 promotes triple-negative breast cancer progression and paclitaxel resistance via MRPS23 protein. Heliyon. 2024;10(17):e36469.","journal-title":"Heliyon"},{"issue":"4","key":"2232_CR56","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.hoc.2025.04.005","volume":"39","author":"MW Bishop","year":"2025","unstructured":"Bishop MW, Osteosarcoma. Diagnosis, Treatment, and Emerging Opportunities. Hematol Oncol Clin North Am. 2025;39(4):749\u201360.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"24","key":"2232_CR57","doi-asserted-by":"publisher","first-page":"11803","DOI":"10.18632\/aging.102448","volume":"11","author":"X Wang","year":"2019","unstructured":"Wang X, Peng L, Gong X, Zhang X, Sun R. LncRNA HIF1A-AS2 promotes osteosarcoma progression by acting as a sponge of miR-129-5p. Aging. 2019;11(24):11803\u201313.","journal-title":"Aging"},{"issue":"1","key":"2232_CR58","doi-asserted-by":"publisher","first-page":"7654","DOI":"10.1038\/s41467-024-51882-w","volume":"15","author":"R Chen","year":"2024","unstructured":"Chen R, Lin Z, Shen S, Zhu C, Yan K, Suo C, et al. Citrullination modulation stabilizes HIF-1\u03b1 to promote tumour progression. Nat Commun. 2024;15(1):7654.","journal-title":"Nat Commun"},{"issue":"4","key":"2232_CR59","doi-asserted-by":"publisher","first-page":"526","DOI":"10.4149\/neo_2023_230523N272","volume":"70","author":"J Yan","year":"2023","unstructured":"Yan J, Chen X, Lin J, Sun X, Chen W. LncRNA HIF1A-AS2 mediates imatinib resistance by regulating autophagy in gastrointestinal stromal tumor cells. Neoplasma. 2023;70(4):526\u201333.","journal-title":"Neoplasma"},{"issue":"15","key":"2232_CR60","doi-asserted-by":"publisher","first-page":"6959","DOI":"10.7150\/thno.41792","volume":"10","author":"T Lu","year":"2020","unstructured":"Lu T, Tang J, Shrestha B, Heath BR, Hong L, Lei YL, et al. Up-regulation of hypoxia-inducible factor antisense as a novel approach to treat ovarian cancer. Theranostics. 2020;10(15):6959\u201376.","journal-title":"Theranostics"},{"issue":"11","key":"2232_CR61","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1016\/j.celrep.2016.05.018","volume":"15","author":"M Mineo","year":"2016","unstructured":"Mineo M, Ricklefs F, Rooj AK, Lyons SM, Ivanov P, Ansari KI, et al. The Long Non-coding RNA HIF1A-AS2 Facilitates the Maintenance of Mesenchymal Glioblastoma Stem-like Cells in Hypoxic Niches. Cell Rep. 2016;15(11):2500\u20139.","journal-title":"Cell Rep"},{"key":"2232_CR62","doi-asserted-by":"publisher","first-page":"625884","DOI":"10.3389\/fonc.2020.625884","volume":"10","author":"O Rezaei","year":"2021","unstructured":"Rezaei O, Tamizkar KH, Sharifi G, Taheri M, Ghafouri-Fard S. Emerging Role of Long Non-Coding RNAs in the Pathobiology of Glioblastoma. Front Oncol. 2021;10:625884.","journal-title":"Front Oncol"},{"key":"2232_CR63","doi-asserted-by":"publisher","first-page":"154887","DOI":"10.1016\/j.prp.2023.154887","volume":"251","author":"F Li","year":"2023","unstructured":"Li F, Chen X. Contribution and underlying mechanisms of lncRNA TRPM2-AS in the development and progression of human cancers. Pathol Res Pract. 2023;251:154887.","journal-title":"Pathol Res Pract"},{"issue":"4","key":"2232_CR64","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.ncrna.2024.06.015","volume":"9","author":"B Eldakhakhny","year":"2024","unstructured":"Eldakhakhny B, Sutaih AM, Siddiqui MA, Aqeeli YM, Awan AZ, Alsayegh MY, et al. Exploring the role of noncoding RNAs in cancer diagnosis, prognosis, and precision medicine. Noncoding RNA Res. 2024;9(4):1315\u201323.","journal-title":"Noncoding RNA Res"},{"issue":"3","key":"2232_CR65","doi-asserted-by":"publisher","first-page":"439","DOI":"10.5603\/rpor.106487","volume":"30","author":"C Saini","year":"2025","unstructured":"Saini C, Vats P, Maharshi S, Baweja B, Nema R. Involvement of lncRNA in cancer diagnosis and prognosis and clinical implications. Rep Pract Oncol Radiother. 2025;30(3):439\u201350.","journal-title":"Rep Pract Oncol Radiother"},{"issue":"7","key":"2232_CR66","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.3390\/ijms25073630","volume":"25","author":"F Nappi","year":"2024","unstructured":"Nappi F, Non-Coding RNA-T, Therapy. A State-of-the-Art Review. Int J Mol Sci. 2024;25(7):3630.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2232_CR67","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s43556-024-00239-2","volume":"6","author":"Y Gu","year":"2025","unstructured":"Gu Y, Yang R, Zhang Y, Guo M, Takehiro K, Zhan M, et al. Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer. Mol Biomed. 2025;6(1):2.","journal-title":"Mol Biomed"},{"issue":"21","key":"2232_CR68","doi-asserted-by":"publisher","first-page":"e39857","DOI":"10.1016\/j.heliyon.2024.e39857","volume":"10","author":"J Yang","year":"2024","unstructured":"Yang J. Emerging roles of long non-coding RNA FOXP4-AS1 in human cancers: From molecular biology to clinical application. Heliyon. 2024;10(21):e39857.","journal-title":"Heliyon"},{"key":"2232_CR69","doi-asserted-by":"publisher","first-page":"587422","DOI":"10.3389\/fonc.2020.587422","volume":"10","author":"JW Li","year":"2021","unstructured":"Li JW, Zhou J, Shi ZT, Li N, Zhou SC, Chang C. Sonographic Features of Triple-Negative Breast Carcinomas Are Correlated With mRNA-lncRNA Signatures and Risk of Tumor Recurrence. Front Oncol. 2021;10:587422.","journal-title":"Front Oncol"},{"issue":"5","key":"2232_CR70","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.3390\/ijms26052294","volume":"26","author":"JM Wang","year":"2025","unstructured":"Wang JM, Lv JS, Liu KH, Li YY, Zhu JJ, Xiong Y, et al. Circ_0011446 Regulates Intramuscular Adipocyte Differentiation in Goats via the miR-27a-5p\/FAM49B Axis. Int J Mol Sci. 2025;26(5):2294.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2232_CR71","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3390\/biom12020332","volume":"12","author":"TM Marques","year":"2022","unstructured":"Marques TM, Gama-Carvalho M. Network Approaches to Study Endogenous RNA Competition and Its Impact on Tissue-Specific microRNA Functions. Biomolecules. 2022;12(2):332.","journal-title":"Biomolecules"},{"issue":"Suppl 1","key":"2232_CR72","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12863-024-01251-9","volume":"25","author":"S Ren","year":"2024","unstructured":"Ren S, Lee W, Park B, Han K. Constructing lncRNA-miRNA-mRNA networks specific to individual cancer patients and finding prognostic biomarkers. BMC Genom Data. 2024;25(Suppl 1):67.","journal-title":"BMC Genom Data"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02232-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02232-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02232-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:03:08Z","timestamp":1788307388000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02232-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,21]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2232"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02232-1","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,21]]},"assertion":[{"value":"18 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Ethics approval and consent to participant","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"314"}}